SEC Form 4 · accession 0001387131-16-003875
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
June Sherie Almenoff
Director
Period of report
Jan 7, 2016
Accepted (ET)
Jan 11, 2016 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.14 | Jan 7, 2016 | A | 60,000 | A | — | Jan 6, 2021 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F11/3 of the shares of common stock subject to the stock option became exercisable immediately, and 1/3 of the shares of common stock subject to the stock option will become exercisable on each of January 7, 2017 and January 7, 2018.